PreciseDx Company
PreciseDx is the only Cancer Risk Stratification company to provide patient-specific risk information through the analysis of morphology.
Industry:
Data processing
Headquarters:
New York, New York, United States
Founded Date:
2019-01-01
Employees Number:
1-10
Funding Status:
Early Stage Venture
Investors Number:
4
Total Funding:
10750000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2022-01-11
Last Funding Type:
Series A
Register and Claim Ownership